Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-046312
Filing Date
2024-11-13
Accepted
2024-11-13 07:30:32
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20037228_10q.htm   iXBRL 10-Q 1214893
2 EXHIBIT 31.1 ef20037228_ex31-1.htm EX-31.1 8854
3 EXHIBIT 31.2 ef20037228_ex31-2.htm EX-31.2 8883
4 EXHIBIT 32.1 ef20037228_ex32-1.htm EX-32.1 6477
5 EXHIBIT 32.2 ef20037228_ex32-2.htm EX-32.2 6378
11 image0.jpg GRAPHIC 164126
12 image00001.jpg GRAPHIC 24669
13 image3.jpg GRAPHIC 56500
14 image00007.jpg GRAPHIC 115850
15 image00008.jpg GRAPHIC 59059
16 image00009.jpg GRAPHIC 52549
17 image00010.jpg GRAPHIC 23269
18 image00011.jpg GRAPHIC 30827
  Complete submission text file 0001140361-24-046312.txt   6838563

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grce-20240930.xsd EX-101.SCH 35182
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grce-20240930_cal.xml EX-101.CAL 36791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grce-20240930_def.xml EX-101.DEF 189881
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grce-20240930_lab.xml EX-101.LAB 513195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grce-20240930_pre.xml EX-101.PRE 295762
77 EXTRACTED XBRL INSTANCE DOCUMENT ef20037228_10q_htm.xml XML 803727
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 241451182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)